Innovative Pharmaceutical Biotech Limited announced consolidated earnings results for the year ended March 31, 2021. For the full year, the company reported revenue was HKD 15,189,000 against HKD 14,580,000 a year ago. Loss for the year was HKD 212,155,000 against HKD 222,462,000 a year ago. Loss for the year attributable to owners of the company was HKD 204,939,000 against HKD 211,117,000 a year ago. Basic and diluted loss per share was HK 14 cents against HK 14.42 cents a year ago.